BACKGROUND Thyroid cancer is a relatively uncommon malignancy accounting for less than 1% of all new malignancies. It is a slowly progressing disease and has an overall favourable outcome with only 9% of patients dying from it. The relatively indolent nature of thyroid malignancy is generally ascribed to the innocuous biological behaviour that is characteristic of these neoplasms. Among the various types of thyroid cancers, papillary carcinoma is the most common form followed by follicular and medullary carcinoma. Of all the thyroid carcinomas, papillary carcinoma has better prognosis. Anaplastic thyroid carcinoma usually assumes an aggressive course and is rapidly lethal, carrying the poorest prognosis of all. Most patients present with a palpable swelling in the neck which initiates assessment through a combination of history, physical examination, and FNA biopsy. MATERIALS AND METHODS This is a retrospective study of 50 cases of primary malignant tumours of thyroid diagnosed and treated in Osmania General Hospital and MNJ institute of oncology between June 2008 and November 2010 RESULTS The mean age of thyroid malignancy was 35.46 years with a female preponderance. 70% of the patients had papillary carcinoma followed by follicular carcinoma in 24%, Hurthle cell variant in 4% and lymphoma in the rest. Most of the cases (56%) had presented with solitary thyroid nodule and a history of duration between one to two years in 17 patients. Cervical lymph node enlargement was found in 17.14% of patients with papillary carcinoma. CONCLUSION Thyroid cancer is a common endocrine neoplasm which can occur most commonly between age groups of 21-65 years. Women are frequently affected. Usual mode of presentation is solitary thyroid enlargement with papillary carcinoma as the common type. Lymphatic spread is common with papillary carcinomas.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.